Harris C.S.,University of Ottawa |
Harris C.S.,Canadian Institute of Health Research Team |
Beaulieu L.-P.,University of Ottawa |
Beaulieu L.-P.,Canadian Institute of Health Research Team |
And 19 more authors.
Planta Medica | Year: 2011
Nonenzymatic formation of advanced glycation end products (AGEs) is accelerated under hyperglycemic conditions characteristic of type 2 diabetes mellitus and contributes to the development of vascular complications. As such, inhibition of AGE formation represents a potential therapeutic target for the prevention and treatment of diabetic complications. In the present study, ethanolic extracts of 17 medicinal plants were assessed for inhibitory effects on in vitro AGE formation through fluorometric and immunochemical detection of fluorescent AGEs and N--(carboxymethyl)lysine adducts of albumin (CMLBSA), respectively. Most extracts inhibited fluorescent AGE formation with ICvalues ranging from 0.4 to 38.6 g/mL and all extracts reduced CMLBSA formation but to differing degrees. Results obtained through both methods were highly correlated. Antiglycation activities were positively correlated with total phenolic content, free radical scavenging activity and reduction in malonyldiadehyde levels following oxidation of low-density lipoprotein, but negatively correlated with lag time to formation of conjugated dienes. Together, these results provide evidence that antioxidant phenolic metabolites mediate the antiglycation activity of our medicinal plant collection, a relationship that likely extends to other medicinal and food plants. © 2011 Georg Thieme Verlag KG Stuttgart New York.